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Abstract
Healthcare-associated infections (HAIs) continue to be a tremendous issue today. It is estimated 1.7 million HAIs
occur per year, and cost the healthcare system up to $45 billion annually. Surgical site infections (SSIs) alone
account for 290,000 of total HAIs and approximately 8,000 deaths. In today’s rapidly changing world of medicine, it
is ever important to remain cognizant of this matter and its impact both globally and on the individual lives of our
patients. This review aims to impress upon the reader the unremitting significance of HAIs in the daily practice of
medicine. Further, we discuss the etiology of HAIs and review successful preventive measures that have been
demonstrated in the literature. In particular, we highlight preoperative, intraoperative, and postoperative interventions
to combat SSIs. Finally, we contend that current systems in place are often insufficient, and emphasize the benefits of
institution-wide adoption of multiple preventive interventions. We hope this concise update and review can inspire
additional dialogue for the continuing progress towards improving patient care and patient lives.
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Introduction
Since the early beginnings of modern medicine, nosoco-
mial infections or healthcare-associated infections (HAIs)
have come hand in hand with any progress in medicine
and surgery. Without question, we have come a long way
since the days the “good old surgical stink” was lauded.
This now gone era was a time when surgeons took pride
in their accumulated filth as a mark of their experience
and professional status, and would thus regularly operate
with bloodstained, unwashed garments [1]. Much of the
progress since then is owed to Joseph Lister, an English
surgeon who is considered the father of antiseptic surgery.
He championed carbolic acid sterilization, hand washing,
clean garments and gloves [2]. Later on, the discovery of
penicillin in 1928 and its mass production in the 1940s in-
creasingly tipped the scales in our favor. And for some
time, it seemed like we were on the brink of victory in the
war against HAIs. Yet any sort of celebration was short-
lived, for as our antibiotics became stronger and more
pervasive, certain strains of bacteria brooded in defiance
and soon emerged resistant to our drugs.
Further, as the field of medicine advanced, its very
landscape changed—hospitals grew larger, patient lives
extended well beyond what was ever thought possible,
and the kinds of diseases doctors treated shifted towards
that of a chronic nature. This came with consequences
that became apparent too late. The unbridled use of anti-
biotics increased the life expectancy of patients with
chronic illnesses, but at the cost of harboring resistant mi-
croorganisms. Subsequently, these bugs slowly spread be-
yond the doors of the hospital until these fugitive strains
became part of the normal flora in the community.
This is the matter at hand today, and indeed the impli-
cations are enormous, astronomical even, if we fail to re-
main vigilant. The Centers for Disease Control (CDC)
estimated in 2002 that 1.7 million HAIs occur annually
and about 1 in 20 hospitalized patients will develop an
HAI, of which, 99,000 will result in deaths [3]. In terms
of healthcare expenditure, the annual direct cost of HAIs
is approximately $28-45 billion [4]. Greater still are the
costs to a patient when a seemingly “run-of-the-mill”
medical or surgical procedure unexpectedly turns into a
fight for his or her life. Such was the case for 34 patients
in Harborview Medical Center in 1980 when a man with
35% total-body-surface-area burn was transferred from a
burn unit endemic with methicillin-resistant S. aureus.
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resistant S. aureus was transmitted to 34 other patients.
Ultimately, 27 were infected and 17 of the 34 died [5].
At present we live in a world of unparalleled capability
in science, technology, and medicine. Things that were
once only imagined in fiction and sci-fi movies are
quickly becoming our reality. Not only do we routinely
perform heart and lung transplants, but we have entered
the realm of face and hand transplantation. Despite all
these advances, health-care associated infections have re-
peatedly proven to remain a formidable force that looms
in the background—one that if we don’t actively and
continually combat can threaten to undo any good we
strive to accomplish.
Definition
Healthcare-associated infection is officially defined by
the CDC/National Healthcare Safety Network (NHSN)
Surveillance as “a localized or systemic condition result-
ing from an adverse reaction to the presence of an infec-
tious agent(s) or its toxin(s) [6,7]. There must be no
evidence that the infection was present or incubating at
the time of admission to the acute care setting.” The
“big four,” which are the 4 most common types, are
urinary tract infections (UTI), surgical site infections
(SSI), bloodstream infections (BSI), and pneumonia
(PNEU) [6,7]. SSIs account for roughly 1/3 of all HAIs,
and catheter-associated BSIs, catheter-associated UTIs,
and ventilator-associated pneumonias account for the
remaining 2/3 [6,7].
SSIs are classified into incisional and organ/space, with
specific criteria for each [6,7]. Incisional is sub-classified
into superficial incisional, involving only the skin and
subcutaneous tissue, and deep incisional, involving fascia
and muscle. Organ/space SSI involves any part of the
body that was opened or manipulated during the oper-
ation, excluding the incision, fascia, and muscle layers.
For a more detailed description of each, including signs/
symptoms, please refer to CDC/NHSN criteria [6,7].
Goals
The goal of this review is to impress that this issue
should be paramount to the daily practice of medicine.
To that aim, we provide an update and succinct sum-
mary of the literature regarding the etiology of HAIs and
highlight some preventive measures that can be success-
fully implemented, specifically concerning SSIs. We also
briefly introduce a novel treatment methodology that
our lab has been developing as a potential avenue to
combat nosocomial SSIs. Lastly, we want to emphasize
the implications of this issue to the healthcare system
and to the individual patient.
Pathophysiology/etiology
The etiology of HAIs is undeniably multifactorial. How-
ever, the source of contamination can often be attributed
to the endogenous skin flora of either the patient or hos-
pital staff [8-10]. There are two categories of flora: resident
and transient [9,11,12]. Resident flora are microorganisms
that normally colonize an individual and live in harmony
with the host, usually providing some benefit or protec-
tion [9,11,12]. Conversely, transient flora are microor-
ganisms picked up from the environment. They often
do not survive very long on the host, but are easily
transmissible from one to another or back to the envir-
onment [9,11,12].
Often referred to as the human “microbiota”, the resi-
dent flora vastly outnumber human host cells by 10–100
times and form a commensal community. Over the past
decade, new sequencing technologies and emerging fields
such as metagenomics have enabled researchers to begin
characterizing this intricate, dynamic micro-ecosystem
and its implication on host health and disease [12-16]. It
is thought that a disruption or alteration of the complex
interactions among human cells and endogenous microor-
ganisms can lead to disease states, such as autoimmune,
metabolic, infectious, inflammatory, and even psycho-
logical disorders. In the realm of HAIs, studies have sug-
gested that the microbiota can act as a physical barrier to
colonization and/or keep the potential virulence of some
endogenous microorganisms in check [12-16]. An insult
to host homeostasis whether as a consequence of surgery
or another process may in fact disturb the balance of this
delicate ecosystem, permitting the overgrowth of specific
strains of resident flora with pathogenic potential and/or
colonization of transient flora, transmitted by the environ-
ment or by hospital staff [12-16].
Some of the most common microorganisms that ac-
count for HAIs include coagulase-negative staphylococci,
Staphylococcus aureus, Enteroccocus species, Candida,
Escherichia coli, Pseudomonas, and Klebsiella [17]. There
is a significant percentage of HAIs associated with
multidrug-resistant pathogens (~16%) [17]. The most
common includes Methicillin-resistant Staphylococcus
aureus (MRSA), accounting for 8%, Vancomycin-resistant
Enterococci faecium (VRE), and Carbapenem-resistant P.
aeruginosa [17]. About 25-30% of the community is
now colonized by S. aureus and up to 5% are colonized
with MRSA [18].
These microorganisms spread through many routes.
The most common of which includes contact, air, water,
and vehicle.
￿ Contact transmission is by direct contact, and per-
haps the most common and easiest way for resident and
transient flora to spread to a susceptible patient. It is also
the route most easily traced back to healthcare workers
and staff. This is often due to improper hand hygiene,
Tsai and Caterson Patient Safety in Surgery 2014, 8:42 Page 2 of 13
http://www.pssjournal.com/content/8/1/42poor antiseptic technique, contaminated needles, instru-
ments, or dressings.
￿ Air transmission is often invisible and insidious
since microorganisms carried in the form of airborne
droplets can travel long distances, especially if ventila-
tion is poor. Coughing and sneezing are common ways
these pathogens can become airborne. A proper filtra-
tion system in place is helpful to prevent hospital-wide
transmission.
￿ Water transmission is an underappreciated route
for the spread of pathogens. Contaminated hospital water
can cause devastating nosocomial outbreaks. It is esti-
mated that waterborne pseudomonas infections kill 1400
annually in the US [19]. Moreover, opportunistic fungi are
also a significant threat, especially to immunocomprom-
ised patients [20,21].
￿ Vehicle transmission is by contaminated surfaces
and objects such as food, medications, devices, and equip-
ment. This mode, like contact transmission, is often the
cause of cross-transmission among susceptible patients,
and can easily cause an outbreak. Objects likely to harbor
viable pathogens are known as fomites and includes com-
mon day use objects like stethoscopes, marking pens, ties,
and ID lanyards. Studies have shown that stethoscopes are
commonly colonized with S. aureus and MRSA, and that
physicians have poor stethoscope cleaning practices
[22-24]. Contaminated environmental surfaces are also
an important aspect of this mode of transmission. Path-
ogens easily cross-transmit via bed rails, call buttons,
trays, chairs, door handles, tabletops, and also through
improperly cleaned equipment such as ultrasound ma-
chines or defibrillators.
Preventive measures
Below, we have compiled a concise summary of the most
common preventive measures in the literature. Peri-
operative measures are broken down into preoperative,
intraoperative, and postoperative to highlight the many
considerations before, during, and after a procedure.
This is not meant to be conclusive, but rather, a quick
resource from which a dialogue can be sparked regard-
ing what more can be done to prevent nosocomial SSIs.
For a more comprehensive look into grades of recom-
mendations and levels of evidence, please refer to Bosco
et al., Savage et al., or Fletcher et al. [25-27].
Hand hygiene
Improved hand hygiene is the most important preventive
measure we can take. Yet compliance is often low. Health-
care workers often forget or don’ts p e n de n o u g ht i m e
washing. The CDC recommends washing for at least 20
seconds or the duration of the “Happy Birthday” song
sung twice [28]. The World Health Organization (WHO)
has developed a multimodal approach to improve hand
hygiene compliance. In a study done during a two-year
period in Costa Rica, Italy, Mali, Pakistan, and Saudi
Arabia, they implemented their approach and found that
overall compliance increased from 51.0% to 67.2% [29].
Their strategy consists of five main components: access,
training and education, monitoring and feedback, visual
reminders, and creation of culture. The WHO details 5
key moments hand hygiene should be practiced [30]:
1. Before touching a patient
2. Before clean and aseptic procedures
3. After contact with bodily fluids
4. After touching a patient
5. After touching a patient’s surroundings
The question of which method of hand-washing is
better, traditional hand-scrubbing or hand-rubbing with
aqueous alcoholic solution has been studied. The gen-
eral consensus is that if your hands are visibly dirty,
traditional hand-scrubbing with soap and water is best.
Otherwise, hand-rubbing with aqueous alcohol is com-
parable [27,31-34]. A randomized equivalence trial com-
pared the two and looked at a total of 4387 consecutive
patients who underwent clean and clean-contaminated
surgery. SSI rates were 55/2252 (2.44%) in hand-rubbing
versus 53/2135 (2.48%) in hand-scrubbing [32]. How-
ever, compliance was much better in hand-rubbing,
presumably due to ease and access, compared to hand-
scrubbing (44% vs 28%). There was also better toler-
ance, less skin dryness, and irritation [32].
Directed antibiotic therapy
With the increased emergence and threat of multi-drug
resistant microorganisms, narrow-spectrum, directed anti-
biotic therapy is imperative. Broad-spectrum antibiotics
should be exercised with restraint and only used as an
initial temporizing measure until a specific diagnosis of
the inciting pathogen is reached. Subsequently, they
should immediately be discontinued and substituted
with narrow-spectrum antibiotics. Reduction of broad-
spectrum antibiotic use can undoubtedly be curtailed
with the aid of faster, more reliable molecular diagnostic
techniques. Next generation methodologies such as PCR
sequencing, sonication, and FISH have shown much
promise, and have been proven superior to traditional
culturing methods in terms of turnover, sensitivity, and
accuracy [35-40]. The continued advancement of these
molecular tools will revolutionize the way we detect and
identify microorganisms, and ultimately permit rapid,
tailored antimicrobial therapy from the very get-go.
Preoperative protocols
There are several preoperative protocols that show prom-
ise in decreasing incidence of HAIs. Some protocols,
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sources should therefore be shifted to those that yield a
significant difference.
￿ Screening for Methicillin-sensitive Staphylococcus
aureus and MRSA:
As mentioned, 25-40% of community is colonized with
S. aureus [41-43]. The bacteria usually reside in the an-
terior nares. Carriers have been shown to be at higher
risk of staphylococcus infections and are 2-9× as likely
to have SSI [41-43]. They are also at higher risk of noso-
comial blood stream infections and lower respiratory in-
fections [44-46].
In 2002, Perl et al. [47] looked to determine if intranasal
mupirocin reduced rate of S. aureus infections at surgical
sites and prevents other nosocomial infections versus
placebo. In this randomized, double-blind, placebo-
controlled trial, they randomly assigned patients, both
carriers and non-carriers, to either the treatment arm or
placebo arm. Their results indicated that the interven-
tion did not significantly decrease rates of S.aureus SSI
overall, but did significantly reduce the rate of nosoco-
mial S. aureus among carriers (4.0% vs 7.7%) [47]. This
suggested the intervention would be more beneficial for
nasal carriers rather than an institutional-wide prophy-
lactic treatment for all patients.
As such, a number of institutions implemented a screen-
ing process followed by decolonization. In one random-
ized, double-blind, placebo-controlled multicenter study,
rapid identification of carriers by polymerase chain reac-
tion followed by treatment with mupirocin nasal ointment
and chlorhexidine soap reduced nosocomial S. aureus
infections. The rate of S. aureus infection was 3.4% (17
of 504 patients) in the treatment group versus 7.7% (32
of 413 patients) in the placebo group [48]. Similarly, a
prospective cohort study of total joint replacement pa-
tients demonstrated a decrease in SSI rate in interven-
tion patients from 2.7% (20/741) to 1.2% (17/1440) [49].
One of the concerns with prophylactic mupirocin ad-
ministration is the development of resistance. In their
study, Perl et al. [47] only identified 4 isolates resistant to
mupirocin. Three were obtained from those not treated
with mupirocin. They concluded that a single, short course
did not appear to select for resistant isolates.
￿ Decolonizing hospital personnel:
Following the same principle as preoperative decoloni-
zation of patients, one preliminary study looked at the
effects of decolonizing hospital personnel, specifically
the surgical team [50]. Carriers were identified among
team members (surgeons, anesthesiologists, nurses) and
subsequently treated with intranasal mupirocin. Retro-
spectively, 1000 consecutive patients had yielded 6% SSI
rate. Post-intervention, of 300 consecutive patients, there
was a 0% SSI rate [50]. Undoubtedly, more studies are
needed, but this preliminary finding is important since
healthcare personnel are often at fault in the transmis-
sion of microorganisms. Institution-wide screening and
decolonization of personnel may be a feasible and suc-
cessful preventive measure. At present most hospital sys-
tems have no screening methodology for employees with
regards to resistant microorganisms. This is in contrast to
mandated tuberculosis screening, which overall has a sig-
nificantly decreased impact on the healthcare system.
￿ Showering or bathing with skin antiseptics:
A Cochrane systematic review investigated the common
practice of preoperative bathing/showering with skin anti-
septics as a measure to reduce SSIs. They looked at 7 ran-
domized controlled trials with a total of more than 10,000
patients that tested chlorhexidine solution against normal
soap or no preoperative washing. They found no evidence
suggesting a clear benefit [51]. Accordingly, it may be
wiser to spend effort on more effective interventions.
￿ Antiseptic skin cloths:
Another proposed preoperative intervention is the
local application of antiseptic solution at the planned
surgical site. In a prospective RCT, Murray et al. [52] in-
vestigated the efficacy of the home application of a 2%
chlorhexidine gluconate (CHG) cloth before shoulder
surgery in decreasing the skin surface levels of bacteria.
The overall positive culture rate in the treatment group
vs control group was 66% vs 94% (p = 0.0008). The posi-
tive culture rate for coagulase-negative Staphyloccocus
was 30% vs 70% (p = 0.0001) [52]. However, there were
no infections in either group, so they were unable to dir-
ectly correlate the reduction in culture rates with infec-
tion rates. Nevertheless, the culture rates do suggest a
potential benefit, especially at the low cost of $3/package
of 2 chorhexidine gluconate cloths [52].
In terms of definitive SSI rates, Eiselt [53] demon-
strated its reduction in orthopedic patients undergoing
joint replacements. Patients used a 2% CHG no-rinse
cloth the night before the surgery and in the preopera-
tive area immediately before the surgery. The control
group was historical, prior to the intervention, and in-
cluded 727 patients, and the treatment group, prospect-
ive, included 736 patients. A significant reduction in SSI
rate was demonstrated after the implementation of CHG
cloths (3.19% vs. 1.59%) [53].
Likewise, Graling et al. [54] conducted a prospective co-
hort study that included 284 patients as a historical con-
trol vs 335 patients who received CHG cloth intervention.
The overall infection rate was decreased from 6.3% (18/
284) to 2.1% (7/335) (p = 0.01). Their economic analysis
differed slightly from Murray’s. They estimated a total fi-
nancial burden of $7 per patient, allotting $2/patient for
nursing time for patient education and assistance. This is
still considerable cheaper than the costs associated with
patient morbidity and increased length of stay due to a
SSI (estimated at ~ $25,000 per SSI) [55].
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A Cochrane systematic review investigated the routine
practice of preoperative hair removal. They looked to
determine if routine removal compared to no removal
and the timing or methods of removal influenced the
rate of SSIs. 14 trials were included. No statistically sig-
nificant evidence was found that indicated hair removal
influences SSI rate; however, evidence did suggest that if
hair removal was necessary to facilitate surgery or appli-
cation of adhesive dressings, clipping compared with
shaving reduces the rate of SSIs [56]. Three trials (1343
participants) compared the two, and demonstrated signifi-
cantly more SSIs associated with shaving than clipping
(Relative Risk 2.09, 95% CI 1.15 to 3.80) [56] (Table 1).
Intraoperative protocols
￿ Antibiotics:
Prophylactic administration of antibiotics has been
proven effective in reducing the rate of postoperative in-
fections for orthopedic, neurological, and spinal surgeries.
In a meta-analysis of randomized controlled trials (RCTs)
of spine fusion surgery, Baker et al. reported a significant
reduction in SSIs, up to 63%, odds ratio 0.37 (95% CI
0.17-0.78) [57]. Similarly, other studies have substantiated
the efficacy of perioperative antibiotics in general orthope-
dics, total joint replacement, and spinal surgery [58,59].
Several guidelines exist for the prophylactic adminis-
tration of antibiotics. Generally, they advocate a broad-
spectrum antibiotic with excellent coverage of S. aureus
such as a first or second-generation cephalosporin (e.g.
cefazolin or cefuroxime). For those with beta-lactam aller-
gies, clindamycin or vancomycin should be administered
instead. Moreover, those who are at high risk of
colonization with MRSA or have had a previous MRSA
infection should be considered for prophylaxis with
vancomycin.
As for timing and duration, high serum and tissue
levels of antibiotic should be sufficiently obtained prior
to the first incision. Therapy should be initiated within
one hour prior to incision, and stopped within 24 hours
of closure. Duration greater than 24 hours may lead to
superinfection with drug-resistant organisms [60]. For
surgical procedures that are prolonged > 4 hours or
incur > 1500 mL of estimated blood loss, a re-dosing is
recommended [61]. Lastly, the compliance of timing,
duration, and selection of antibiotics is improved from
65% to 99% if the protocol is incorporated into the
“time-out” [62].
￿ Skin preparation:
Prior to incision, the surgical site is often prepared by
sterilizing the skin. Most commonly, a commercial skin
antiseptic solution is applied such as Chloraprep (2%
chlorhexidine gluconate and 70% isopropyl alcohol),
DuraPrep (0.7% iodine and 74% isopropyl alcohol), or
Betadine (0.75% iodine scrub, 1.0% iodine paint). Several
studies have been conducted to compare the efficacy of
these common preparation solutions. Ostrander et al. re-
ported that ChloraPrep was superior to DuraPrep and
Technicare in terms of eradicating bacteria from the
skin, with decreased rates of positive cultures (30% vs.
65% vs. 95%, respectively, p < 0.0001) [63]. On the other
hand, Savage et al. found no statistically significant
difference in the rate of positive cultures between Chlor-
aPrep and DuraPrep in a prospective study of 100 con-
secutive patients undergoing lumbar spinal surgery (0%
vs 6%, p = 0.25) [64].
As for infection rates, a prospective cohort study that
enrolled 3,209 patients found that DuraPrep was associ-
ated with the lowest rate compared with Betadine and
ChloraPrep (3.9% vs. 6.4% vs. 7.1%, p = 0.002) [65]. Con-
versely, a multicenter prospective RCT reported Chlora-
Prep was associated with a lower rate of SSI than
Betadine (9.5% vs. 16.1%, p = 0.004, risk ratio 0.59, 95%
CI 0.41-0.85) [66].
As it stands, there is no clear evidence that one prep-
aration solution is the better choice in effectively lower-
ing rate of SSI.
￿ Wound irrigation:
Wound irrigation is one of the oldest surgical mantras,
and many a medical student has heard their attendings
Table 1 Summary of preoperative interventions
Preoperative interventions Summary References
Screening for MSSA and MRSA ● Screening and prophylactic decolonization may prevent nosocomial
S. aureus infections in carriers
[47-49]
Decolonizing hospital personnel ● Preliminary study finds reduction of SSI rate with decolonization of
hospital personnel carriers
[50]
Showering or bathing with antiseptics ● Cochrane review of 7 RCTs finds no evidence of clear benefit [51]
Antiseptic skin cloths ● Preoperative application of CHG cloths on planned surgical sites
decreases skin surface levels of bacteria and may reduce SSI rate
[52-54]
Hair removal ● Cochrane review finds no evidence that hair removal has any bearing on SSI rates [56]
● However, clipping, compared to shaving, is associated with decreased incidence of SSIs
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helps to remove loose, necrotic tissue, particulate debris,
and microorganisms from within the surgical site. It is
considered the most important intraoperative step in re-
ducing the risk of infection. Traditionally, sterile normal
saline has been used despite concrete, supporting evidence
[67]. In fact, one prospective, randomized, double-blinded
controlled study found that there was no statistically sig-
nificant difference in rates of SSI between irrigation with
saline vs tap water [68].
Irrigation with other solutions has also been suggested.
One prospective RCT looked at the efficacy of dilute
betadine irrigation (3.5% povidone-iodine solution) in
the prevention of postoperative infection in spinal surgery.
The study demonstrated a remarkably lower infection rate
with dilute betadine solution (0%, n = 208) versus normal
saline irrigation (3.5%, n = 206) (p = 0.007) [69]. No ad-
verse side effects or events were reported.
￿ Thermoregulation:
Intraoperative hypothermia has been shown to increase
the risk of SSIs, likely as a consequence of the reduction in
peripheral circulation [70]. This reduction ultimately limits
oxygen concentrations in the tissues, especially in the
wound, where the body needs it most to fight off infections.
Moreover, hypothermia directly impairs immune function.
Warming patients have been demonstrated to reduce in-
fection rates in colorectal surgery [70]. Melling et al. [71]
looked at warming patients before clean surgeries (locally
or systemically) and found the infection rate was 14% in
non-warmed patients (19/139) versus 5% (13/277) in
warmed patients. Among warmed patients, the study
did not demonstrate a statistically significant difference
in infection rates between local and systemic warming.
These studies suggest that maintenance of periopera-
tive normothermia may be a worthwhile endeavor, espe-
cially since it is easily implemented.
￿ Antiseptic-coated sutures:
Sutures coated with the antiseptic triclosan have been
developed to reduce SSIs. Edmiston et al. [72] evaluated
its effectiveness in inhibiting bacterial growth and adher-
ence in an in vitro model. There was > 75% reduction in
gram-positive and gram-negative bacterial adherence to
the antimicrobial suture. Clinically, in a prospective,
double-blinded RCT in pediatric neurosurgical patients,
Rozzelle et al. [73] demonstrated a statistically significant
reduction in infection rates in those treated with anti-
microbial suture (4.3% vs 21%, p = 0.038) undergoing
cerebrospinal fluid shunt procedures. Unfortunately, the
cost-effectiveness of these sutures is yet to be determined.
The antiseptic-coated sutures cost 7% to 10% more than
standard uncoated ones. Nevertheless, they may be justi-
fied in high-risk patients, as was the case with Rozzelle’s
patients, in which they underwent a procedure usually as-
sociated with 5-15% risk of infection [73].
￿ Operating room traffic:
Traffic in and out of the OR increases bacterial counts,
and has been demonstrated to increase infection rates.
The opening and closing of doors likely disrupts the air-
flow, allowing microbes to settle in the air directly above
the surgical field. Panahi et al. [74] looked at the inci-
dence of door opening during primary and revision total
joint arthroplasty procedures. The study found that door
openings averaged 0.65 and 0.84 per minute for primary
and revision procedures, respectively. The average total
door openings per procedure were 60 in primary cases
and 135 in revisions [74].
The intervention here is clearly to limit traffic flow.
This requires education and detailed communication
among surgeons and OR personnel to aid preparation of
the OR with essential instruments and components for
scheduled procedures (Table 2).
Postoperative management
￿ Drains and blood transfusions:
A Cochrane review evaluated the occurrence of infec-
tions in relation to closed suction drainage after ortho-
pedic surgery. 36 studies were included, involving 5464
participants with 5697 surgical wounds identified [75].
The meta-analysis demonstrated no statistically significant
difference in infection rates between those with drains and
those without. They concluded that there is no clear evi-
dence that supports the routine use of closed suction
drains in orthopedic surgery.
The aforementioned study did however find that drain
use was often associated with the need for blood transfu-
sions. Of course, blood transfusions carry its own risk of
infections with blood-borne bacteria, viruses, or para-
sites – albeit a very minimal one. The more pressing risk
associated with blood transfusions is the increased
length of hospital stay and SSI [76]. It is thought that
transfusion evokes an immunomodulation, which affects
wounds and increases risk of infection [77]. Bower et al.
[78] found that patients who received transfusions were
nearly twice as likely to have an infection than those that
did not. More studies are needed to pin down whether
it’s a causal relationship or merely a confounding finding
such that people who are at risk of needing a blood
transfusion are equally at risk for SSIs.
Regardless, blood transfusions do lead to an increased
length of stay as demonstrated by Weber et al. [76]. This
in it of itself is a risk factor for infection, and every effort
should be made to judiciously discern the need for a
transfusion. Preoperative assessment of hemoglobin and
hematocrit levels and monitoring for symptomatic
anemia rather than lab results alone would be beneficial.
￿ Wound management:
Postoperatively, the goal is to keep the surgical site
clean and dry. The CDC recommends surgical dressings
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soaked dressings should be replaced immediately. Other-
wise, any microorganisms nearby can become a source
of infection. Dressings should also be chosen carefully to
ensure they stay intact.
Antimicrobial dressings are available and they may
serve to reduce risk of infection. Silver-based dressings,
in particular, have been shown to be effective in reducing
the rate of mediastinitis following cardiac surgery [80].
Another common wound dressing is the use of nega-
tive pressure wound therapy. There is not much litera-
ture on whether it helps decrease risks of infection. But
by drawing out fluid from the wound, completely sealing
the wound, and cutting down the frequency of dressing
changes, theoretically it should help reduce the inci-
dence of SSIs.
￿ Urinary tract infections:
Although not strictly a SSI, urinary tract infections are
important to mention in the context of postoperative
management, since it is a common complication. The
details, however, are beyond the scope of this review.
Some important principles to keep in mind are the follow-
ing: avoid catherization when possible and remove as soon
as possible; always practice aseptic technique during inser-
tion and maintenance; consider the use of suprapubic and
condom catheters in lieu of urethral catheters, since they
have a lower rate of infection [81]. Finally, in high-risk pa-
tients, silver alloy catheters may have some antimicrobial
benefit [82] (Table 3).
Non-operative preventive measures
Briefly, we would like to mention some other preventive
measures. These are not specifically related to SSIs but
are more general measures. The multifactorial etiology
of health-care associated infections precludes successful
prevention in a vacuum of its subtypes (i.e. SSIs, UTIs,
BSIs, PNEUs), so it is important to be cognizant of these
other measures. For more information, Curtis provides a
detailed review on a number of these interventions [83].
￿ Cleaning:
Proper cleaning is an important aspect of preventing
health-care associated infections. Contaminated environ-
mental surfaces often lead to cross-transmissions, and
increase rates of infection. Hospitals should train clean-
ing personnel adequately, monitor performance regu-
larly, and provide feedback. Moreover, they should make
hospital cleaning personnel aware of their vital role in
the ultimate health of the patients. A prospective study
in Illinois compared rates of VRE infection before and
after a cleaning educational program. Rates of VRE in-
fection fell by 64% [95% CI: 0.19-0.68] [84].
There are few studies looking at which chemicals are
best to clean surfaces. However, some studies demon-
strate the effectiveness of a bleach solution. One study
compared the use of 1:10 hypochlorite (bleach) solution
with the use of a quaternary ammonium solution and
found that the former was associated with a significantly
lower rate of C. difficile infection than the latter. An-
other study found that unbuffered 1:10 hypochlorite so-
lution reduced the frequency of positive C. difficile
cultures in patient rooms from 31% to 16%. Finally, a
study of 17 rooms that housed VRE-positive patients
found that prior to cleaning, 16/17 (94%) of the rooms
contained viable VRE. After thorough cleaning with a 10%
bleach solution, the amount of viable VRE decreased to 0
(0%) (p < 0.001) [85].
Hydrogen peroxide vapor has also been shown to be
an effective decontamination method. A British study
compared manual cleaning with hydrogen peroxide vapor.
Prior to manual cleaning, in 10 surgical ward rooms, 89%
Table 2 Summary of intraoperative interventions
Intraoperative interventions Summary References
Prophylactic antibiotics ● Prophylactic antibiotics are effective in reducing SSI rates [57-62]
● Discontinue within 24 hours of closure to prevent superinfection
● Redosing may be beneficial for procedures > 4 hours or if EBL > 1.5 L
● Timing, duration, selection of antibiotics should be incorporated into
the “time-out” to improve compliance
Skin preparation ● No clear evidence that one preparation solution is superior [63-66]
Wound irrigation ● Important to remove loose, necrotic tissue, debris, and
microorganisms from surgical site
[67-69]
● No difference in infection rates between saline and tap water
● Dilute betadine solution may be of benefit
Thermoregulation ● Maintaining perioperative normothermia may reduce SSI rates [70,71]
Antiseptic-coated sutures ● Effective in reducing SSI rates in neurosurgical patients,
but cost-effectiveness has yet to be determined
[72,73]
Operating room traffic ● Limit OR traffic flow [74]
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remained positive after manual cleaning. In comparison, 6
other surgical ward rooms were swabbed and 72% of 85
swabs were positive prior to cleaning. After hydrogen per-
oxide treatment, only 1% of 85 remained positive [86]. An-
other study investigated the feasibility of routine hydrogen
peroxide decontamination in a busy hospital. One draw-
back has always been the mean time for decontamination
with hydrogen peroxide (~90-120 minutes). The study
concluded that the additional time is offset by the drastic
improvement in surface hygiene, and reduction in nosoco-
mial pathogens. They assert its feasibility in a busy hos-
pital with a mean occupancy rate of 94% [87].
￿ Waterborne transmission:
Studies have found that the replacement of tap water
with sterile water for drinking, bathing, and procedures
can significantly reduce infection rates [19]. Other mea-
sures include decontaminating the hospital water supply.
This can be done by heating water to more than 50°C or
with UV light treatment, both of which has been shown
to reduce levels of Legionella [88,89]. Another effective
method is copper-silver-based ionization systems, has
been shown to reduce molds and gram-negative bacteria
such as P. aeuroginosa and Actinetobacter baumannii in
addition to Legionella [20,90,91]. One hospital found le-
gionella infection rates drop from 2.45 cases to 0.18
cases per 1000 discharges subsequent installation of a
copper-silver ionization system [91].
￿ Air filtration/treatment:
High-efficiency particulate air filters can help reduce
aerosolized pathogens and decrease infection rates. Stud-
ies have reported its use decreases airborne aspergillus
concentrations and aspergillus infections [92,93]. More-
over, the use of portable filters has been demonstrated
to significantly reduce airborne levels of MRSA and P.
aeruginosa [94].
Adequate outdoor air ventilation is also important to
help circulate and dilute air that may be ridden with air-
borne pathogens. Indeed, poor ventilation is often asso-
ciated with higher rates of acute respiratory disease [95].
￿ Anti-microbial copper alloy:
As mentioned above, touch surfaces are often a source of
contamination and cross-transmission. Surfaces can often
harbor pathogens for days and even months, becoming a
reservoir of infection. Incorporating anti-microbial cop-
per alloy into these surfaces has been suggested as a
possible solution. Copper’s basic chemical properties and
tendency to produce hydroxyl radicals and cations gives it
a unique broad-spectrum biocidal ability. In vitro stud-
ies have demonstrated its effectiveness in rapidly redu-
cing bacterial concentration by 7 logs within just 2
hours [96-98].
A multi-center study looked at its clinical application
in the ICUs of 3 hospitals. Patients were randomly
assigned to rooms with and without copper alloy surfaces,
and the rates of HAIs and/or colonization with MRSA or
VRE were compared. Six objects were fabricated from
copper alloy, four of which were identical among the
three hospitals: bed rails, overbed tables, IV poles, and
arms of visitor’s chair. Results indicated that the rate of
HAI and/or MRSA or VRE colonization in copper rooms
were significantly lower than non-copper rooms (0.071 vs.
0.123, p = 0.020). The rate for just HAI was decreased
58% from 0.081 to 0.034 (p = 0.013) [98].
Another study found that the combined burden of
MRSA and VRE were 96.8% lower on copper surfaces
than current plastic, wood, metal, and painted surfaces.
Copper surfaces were also found to continuously limit
microbial bioburden, achieving same levels as terminal
cleaning [99]. Copper-alloy surfaces are proving to be a
promising intervention (Table 4).
Developments
At Brigham and Women’s Hospital, in the Laboratory
for Tissue Repair and Gene Transfer, we have developed
a wound enclosure device, which we have previously
shown to be a promising wound healing modality with-
out any adverse side effects [100-103]. It consists of a
polyurethane chamber that envelops the wounds, creat-
ing a controlled incubator-like microenvironment. This
platform allows us to maintain optimal conditions for
wound healing while concomitantly providing both top-
ical antibiotics and analgesics to the wound [100-103].
In addition to wound healing improvement, we have re-
alized its potential as a novel intervention for health-
care associated surgical site infections. These chambers
eliminate the need for daily dressing changes, since fluid
can easily be aspirated and sampled from the chamber
Table 3 Summary of postoperative interventions
Postoperative interventions Summary References
Drains and blood transfusion ● Cochrane review finds no difference in infection rates between those with drains and those without [75-78]
● Blood transfusions increase risk of infection and length of hospital stay
Wound management ● Keep surgical dressings clean and dry Antimicrobial dressings may help reduce infections [79,80]
Urinary tract infection ● Avoid catherization when possible, and always remove as soon as possible [81,82]
● Suprapubic and condom catheters have lower rates of infection
● In high-risk patients, silver alloy catheters may be of benefit
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tion of the wounds, facilitating hospital rounds. This
would significantly decrease the risk of contamination
from hospital personnel.
Using a porcine model, we have been able to dramatic-
ally decrease bacteria concentrations in both wound fluid
and tissue by adding topical antibiotics (up to 1,000 min-
imal inhibitory concentration) within our wound cham-
bers, even after inoculation of wounds with 10
8 colony
forming units/mL (unpublished data). Moreover, our
preliminary studies indicate its ability to rapidly de-
crease bacterial counts of endogenous flora. This has
great implications, since, as mentioned, endogenous
flora is a common source of contamination that leads to
SSI. Similar to the antiseptic skin cloths discussed above,
which have been shown to reduce infection rates, these
chambers may be a safe, more efficacious alternative. The-
oretically, these chambers could be placed preoperatively
on the surgical site to rapidly decolonize endogenous
flora, and also be placed as a wound dressing post-
operatively to further prevent SSIs. Further studies are
planned, but at this point, it looks to be a promising
novel intervention that could easily be implemented.
Numbers and costs
Using data from the National Nosocomial Infections
Surveillance (NNIS) system, National Hospital Discharge
Survey (NHDS), and the American Hospital Association
(AHA) Survey, Klevens et al. estimated 1.7 million HAIs
occurred in U.S. hospitals in 2002. Among these, ap-
proximately 155,000 deaths occurred, 99,000 of which
were considered caused by or significantly associated with
the HAI [3]. This puts HAIs in the top ten leading causes
of death, compared to CDC’s 2010 data for Alzheimer’s
disease (83,494), diabetes (69,071), and kidney diseases
(50,476) [104]. In another study, Scott et al. estimated that
the annual direct cost of HAIs to U.S. hospitals ranges
from $28.4 to $45 billion [4]. With a high estimate that
70% of HAIs are preventable by current available strat-
egies, the economic benefits of prevention ranges from
$25.0 to $31.5 billion. With a low estimate that 20% are
preventable, the savings range from $5.7 to $6.8 billion,
which is still comparable to the healthcare costs of
stroke ($6.7 billion), diabetes mellitus with complica-
tions ($4.5 billion), and chronic obstructive lung disease
(4.2 billion) [105].
Surgical site infections alone account for roughly
290,000 of the total HAIs, and are estimated to cause
8,000 deaths, a case fatality rate of 2.8%. They are the
second most frequently reported HAI [3]. As for the at-
tributable costs of SSIs, Anderson et al. gives a low esti-
mate of $10,443 per infection and Stone et al. gives it a
high estimate of $25,546 per infection [55,106]. From a
patient perspective, wound infections are the second
most commonly experienced adverse event (14%), sec-
ond only to medication errors (19%) [107]. Commonly,
SSIs increase the hospital length of stay (LOS) on aver-
age between 7.3 days and 14.3 days [108]. Moreover,
they increase the risk of re-admittance within 30 days by
5 times, double the mortality rate, and decrease quality
of life [109,110]. In a systematic review, Umscheid et al.
estimated that as much as 55% of SSIs may be prevent-
able. This would equate to approximately 75,526 to
156,862 preventable infections per year and subse-
quently, 2,133 to 4,431 preventable deaths [111].
Final thoughts
Surgical site infections remain a tremendous issue in the
21st century. There are several successful preventive mea-
sures described in the literature; however, an institution-
wide adoption of several of these interventions is often
few and far between. Complacency in this matter is almost
tantamount to negligence. In the spirit of primum non
nocera, we should ever strive to aggressively lower infec-
tion rates as much as we can. Additionally, with the rap-
idly changing climate of our healthcare industry, where
the way we practice and the quality of our care is increas-
ingly scrutinized, infection prevention should be an ut-
most priority.
Although, it is doubtful one single preventive measure
will ever be the be-all and end-all for our problems, there
is hope that bundles of multiple measures can dramatically
Table 4 Summary of non-operative preventive measures
Non-operative preventive measures Summary References
Cleaning ● Hospital cleaning personnel should be made aware of their vital role
in decreasing HAIs; they should be trained appropriately, adequately, and monitored
[84-87]
● Bleach solutions and hydrogen peroxide vapor have been shown to be effective
decontaminating agents
Waterborne transmission ● Replacement of tap water with sterile water may reduce infection rates [88-91]
● Decontaminating hospital water supply may be an alternative
Air filtration ● High-efficiency particulate air filters can help reduce airborne levels of aspergillus,
MRSA, and P. aeruginosa
[92-95]
Anti-microbial copper alloy ● Incorporating copper-alloy in hospital surfaces may limit contamination
and cross-transmission
[96-99]
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whole is greater than the sum of its parts” [112-114].
Alexander et al. suggests that adherence to current guide-
lines and available interventions can reduce infection rates
to less than 0.5% in clean wounds, less than 1% in clean
contaminated wounds, and less than 2% in highly contam-
inated wounds [115]. With a similar mindset, the Mayo
Clinic in Florida instituted multiple interventions as an
SSI Bundle. Thompson et al. [116] details their institu-
tion’s experience and results in their paper aptly titled,
“Chasing Zero”. During the study period between May
2008 and June 2010, they achieved a 57% decrease in SSI
rate with an estimated savings of nearly $1 million (Class I
SSI, clean wounds, rate from 1.78% to 0.51% and Class II
SSI, clean-contaminated, rate from 2.82% to 1.44%) [116].
Conclusion
Health-care associated infections continue to cause sig-
nificant patient morbidity and mortality and account for
a great deal of healthcare costs. Nevertheless, we are op-
timistic that together we are ever moving towards im-
proving patient care. Though many successful preventive
measures exist, more can always be done in terms of re-
search and practicing evidence-based care. We believe
that pushing for an organized institution-wide adoption
of multiple interventions may be the key to reducing in-
fection rates. No doubt each institution differs in cap-
acity and resources, so a discussion is necessary at each
institution on what is feasible. We hope this review and
the work of many others before us can help inspire add-
itional dialogue regarding this matter.
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